Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 4/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 6/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CPS1 | P31327 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | CCNK | O75909 | 2/20 | 0.31 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4432476 | 0.97 | F10 (0.42) | F10MCHR1LMNATP53MAPT | |
| SCHEMBL4592517 | 0.89 | F10 (0.39) | F10MCHR1LMNATP53MAPT | |
| SCHEMBL4592558 | 0.87 | F10 (0.43) | F10MCHR1LMNATP53MAPT | |
| SCHEMBL4433785 | 0.87 | F10 (0.43) | F10MCHR1LMNATP53MAPT | |
| SCHEMBL3309135 | 0.87 | F10 (0.45) | F10LMNAMAPK1 | |
| SCHEMBL8487514 | 0.87 | F10 (0.45) | F10LMNAMAPK1 | |
| SCHEMBL4583790 | 0.85 | SPTLC2 (0.41) | F10MCHR1HDAC6 | |
| SCHEMBL4584319 | 0.85 | F10 (0.44) | F10MCHR1MAPTHDAC6POLB | |
| SCHEMBL4433533 | 0.85 | F10 (0.38) | F10MCHR1LMNAHDAC6 | |
| SCHEMBL4584044 | 0.85 | F10 (0.41) | F10MCHR1HDAC6CCNKCDK12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2132193-B1 | SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS | BOEHRINGER INGELHEIM INT (DE) | 2012-10-24 | — | — | EP | disclosed |
| EP-1975165-A1 | Substituted pyrrolidinamides, their production and utilisation as medicine | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2008-10-01 | — | — | EP | disclosed |